Abingworth

Abingworth is a transatlantic life-sciences investment firm that provides capital and development expertise to biotechnology and biopharma companies. The firm invests across the company lifecycle — from seed and early-stage through clinical development and public-market positions — and operates offices in London, Menlo Park/San Francisco and Boston. Abingworth is part of Carlyle. As of 29 February 2024 the firm reported investments in 185 life-science companies, including multiple M&A transactions and IPOs.